Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DDB1 | Q16531 | 17/20 | 0.54 |
| ▸ | CRBN | Q96SW2 | 17/20 | 0.54 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31202304 | 0.87 | DDB1 (0.56) | DDB1CRBNCHRNA7 | |
| SCHEMBL31202341 | 0.85 | DDB1 (0.59) | DDB1CRBNCHRNA7 | |
| SCHEMBL31202228 | 0.85 | DDB1 (0.57) | DDB1CRBN | |
| SCHEMBL31202219 | 0.85 | DDB1 (0.54) | DDB1CRBNCHRNA7 | |
| SCHEMBL31202079 | 0.85 | DDB1 (0.57) | DDB1CRBN | |
| SCHEMBL31202248 | 0.84 | DDB1 (0.56) | DDB1CRBNCHRNA7 | |
| SCHEMBL24669902 | 0.84 | DDB1 (0.65) | DDB1CRBN | |
| SCHEMBL31201973 | 0.83 | DDB1 (0.57) | DDB1CRBNCHRNA7 | |
| SCHEMBL31202077 | 0.83 | DDB1 (0.56) | DDB1CRBNCHRNA7 | |
| SCHEMBL31202121 | 0.82 | DDB1 (0.53) | DDB1CRBN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240368114-A1 | INDAZOLES, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS | BIOTHERYX INC (US) | 2024-11-07 | — | — | US | claimed |
| US-20240368114-A1 | INDAZOLES, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS | BIOTHERYX INC (US) | 2024-11-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240368114-A1 | INDAZOLES, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS | CSNK1G3, CSNK1A1, CSNK1D | DDB1 3279/4885CRBN 2500/4885CHRNA7 1420/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.